507 related articles for article (PubMed ID: 28743650)
1. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
[TBL] [Abstract][Full Text] [Related]
2. Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis.
Unissa AN; Doss C GP; Kumar T; Sukumar S; Lakshmi AR; Hanna LE
J Glob Antimicrob Resist; 2018 Dec; 15():111-120. PubMed ID: 29990547
[TBL] [Abstract][Full Text] [Related]
3. Insights on the Mechanism of Action of INH-C
Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
Brossier F; Boudinet M; Jarlier V; Petrella S; Sougakoff W
Tuberculosis (Edinb); 2016 Sep; 100():15-24. PubMed ID: 27553406
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).
Suarez J; Ranguelova K; Schelvis JPM; Magliozzo RS
J Biol Chem; 2009 Jun; 284(24):16146-16155. PubMed ID: 19363028
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
[TBL] [Abstract][Full Text] [Related]
7. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches.
Ramasubban G; Therese KL; Vetrivel U; Sivashanmugam M; Rajan P; Sridhar R; Madhavan HN; Meenakshi N
Int J Antimicrob Agents; 2011 Apr; 37(4):368-72. PubMed ID: 21330112
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for isoniazid resistance in KatG double mutants of Mycobacterium tuberculosis.
Rabha A; Singh A; Grover S; Kumari A; Pandey B; Grover A
Microb Pathog; 2019 Apr; 129():152-160. PubMed ID: 30731190
[TBL] [Abstract][Full Text] [Related]
9. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
[TBL] [Abstract][Full Text] [Related]
10. Molecular Analysis of
Purkan P; Ihsanawati I; Natalia D; Syah YM; Retnoningrum DS; Siswanto I
J Med Life; 2018; 11(2):160-167. PubMed ID: 30140323
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
[TBL] [Abstract][Full Text] [Related]
12. Molecular details of INH-C10 binding to wt KatG and Its S315T mutant.
Teixeira VH; Ventura C; Leitão R; Ràfols C; Bosch E; Martins F; Machuqueiro M
Mol Pharm; 2015 Mar; 12(3):898-909. PubMed ID: 25590860
[TBL] [Abstract][Full Text] [Related]
13. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kondo Y; Suetake T; Toyota E; Kato S; Mori T; Kirikae T
Antimicrob Agents Chemother; 2010 May; 54(5):1793-9. PubMed ID: 20211896
[TBL] [Abstract][Full Text] [Related]
14. [Detection of S315T mutation in the katg gene as a strategy for identification of isoniazid-resistant Mycobacterium tuberculosis in a reference laboratory].
Romay Z; Arráiz N; Fuenmayor A; Ramírez C; Rojas L; París R
Rev Chilena Infectol; 2012 Dec; 29(6):607-13. PubMed ID: 23412028
[TBL] [Abstract][Full Text] [Related]
15. Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Grzeszczuk M; Kamiński M; Roeske K; Napiórkowska A; Stachowiak R; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
Pneumonol Alergol Pol; 2013; 81(4):298-307. PubMed ID: 23744165
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
[TBL] [Abstract][Full Text] [Related]
17. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
[TBL] [Abstract][Full Text] [Related]
18. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
Yıldırım E; Uzun M
Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
[TBL] [Abstract][Full Text] [Related]
19. Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.
Ameeruddin NU; Luke Elizabeth H
Tuberculosis (Edinb); 2014 Dec; 94(6):557-63. PubMed ID: 25270728
[TBL] [Abstract][Full Text] [Related]
20. Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy.
Kapetanaki S; Chouchane S; Girotto S; Yu S; Magliozzo RS; Schelvis JP
Biochemistry; 2003 Apr; 42(13):3835-45. PubMed ID: 12667074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
